Dynamics of leukocyte inflammatory markers in patients with ST-elevation myocardial infarction depending on left ventricle ejection fraction
DOI:
https://doi.org/10.14739/2310-1237.2022.3.267268Keywords:
leukocytes, markers of inflammation, ST segment elevation myocardial infarctionAbstract
Aim: to evaluate the dynamics of leukocyte inflammatory markers in patients with ST-elevation myocardial infarction (STEMI) after percutaneous coronary intervention (PCI) depending on ejection fraction of left ventricular (LV).
Material and methods. The study group consisted of 23 consecutive patients with STEMI admitted to the Regional Clinical Cardiology Center in Chernivtsi, who underwent successful reperfusion treatment by PCI. To evaluate inflammatory markers, a complete blood count (CBC) was assessed at admission, and on day 10 of hospital stay on the background of optimal drug therapy.
Results. It was found that patients with STEMI and reduced left ventricular ejection fraction (LVEF) (group 2) at admission had a significantly higher leukocyte count (P < 0.05) and an increase in the absolute neutrophils (P < 0.01) with significantly higher inflammatory markers: neutrophil-to-lymphocyte ratio (NLR) (P < 0.01), monocyte-to-lymphocyte ratio (MLR), systemic immune inflammation index (SII) (P < 0.01), systemic inflammation response index (SIRI) (P < 0.01), aggregate index of systemic inflammation (AISI) (P < 0.05), and integrated index of inflammation (III) (P < 0.05). On day 10 of treatment, the analysis of inflammatory markers showed that in patients of group 2, NLR (P < 0.01) and SII (P < 0.05) remained significantly higher than in STEMI patients with preserved LVEF (group 1). At the study of the changes in leukocyte-based inflammatory markers in STEMI patients under the influence of optimal drug therapy after PCI, a decrease (P < 0.05) in NLR, MLR, SII, SIRI, IIII, and an increase in (P < 0.05) LMR were observed.
Conclusions. CBC of inflammatory markers at admission identifies the risk of adverse cardiovascular events and determines measures to regulate the activity of the inflammatory process in STEMI.
References
Si, Y., Liu, J., Shan, W., Zhang, Y., Han, C., Wang, R., & Sun, L. (2020). Association of lymphocyte-to-monocyte ratio with total coronary plaque burden in patients with coronary artery disease. Coronary artery disease, 31(7), 650-655. https://doi.org/10.1097/MCA.0000000000000857
Dziedzic, E. A., Gąsior, J. S., Tuzimek, A., Dąbrowski, M., & Jankowski, P. (2022). Neutrophil-to-Lymphocyte Ratio Is Not Associated with Severity of Coronary Artery Disease and Is Not Correlated with Vitamin D Level in Patients with a History of an Acute Coronary Syndrome. Biology, 11(7), 1001. https://doi.org/10.3390/biology11071001
Yoon, G. S., Choi, S. H., Woo, S. I., Baek, Y. S., Park, S. D., Shin, S. H., Kim, D. H., Kwan, J., Lee, M. J., & Kwon, S. W. (2021). Neutrophil-to-Lymphocyte Ratio at Emergency Room Predicts Mechanical Complications of ST-segment Elevation Myocardial Infarction. Journal of Korean medical science, 36(19), e131. https://doi.org/10.3346/jkms.2021.36.e131
Fonseca, F. A., & Izar, M. C. (2022). Role of Inflammation in Cardiac Remodeling After Acute Myocardial Infarction. Frontiers in physiology, 13, 927163. https://doi.org/10.3389/fphys.2022.927163
Tavares, F., Moraes, P. I. M., Souza, J. M., Barbosa, A. H., Santos, E. M., Marcondes, J. A., Oliveira, M. D., Gonçalves, I., Jr, Espírito Santo, C. V. A., Bianco, H. T., Fonseca, F. A. H., Moisés, V., & Caixeta, A. (2022). Prognostic role of neutrophil-to-lymphocyte ratio in patients with ST-elevation myocardial infarction undergoing to pharmaco-invasive strategy. Cardiovascular revascularization medicine : including molecular interventions, 34, 99-103. https://doi.org/10.1016/j.carrev.2021.01.027
Anzai, A., Ko, S., & Fukuda, K. (2022). Immune and Inflammatory Networks in Myocardial Infarction: Current Research and Its Potential Implications for the Clinic. International journal of molecular sciences, 23(9), 5214. https://doi.org/10.3390/ijms23095214
Kovalenko, V., Dolzhenko, M., & Potashev, S. (2018). Nastanovy z klinichnoi ekhokardiohrafii [Guidelines for clinical echocardiography]. Kyiv: Naukova dumka. [in Ukrainian].
Li, Q., Ma, X., Shao, Q., Yang, Z., Wang, Y., Gao, F., Zhou, Y., Yang, L., & Wang, Z. (2022). Prognostic Impact of Multiple Lymphocyte-Based Inflammatory Indices in Acute Coronary Syndrome Patients. Frontiers in cardiovascular medicine, 9, 811790. https://doi.org/10.3389/fcvm.2022.811790
Dai, K., Li, Z., Luo, Y., Xiong, Q., Xiong, Y., Song, Z., & Xiong, W. (2022). The Predictive Value of the Monocyte-to-Lymphocyte Ratio and Monocyte-to-Haematocrit Ratio for Cardiac Rupture Patients with Acute Myocardial Infarction: A Propensity Score Matching Analysis. Risk management and healthcare policy, 15, 37-44. https://doi.org/10.2147/RMHP.S348894
Urbanowicz, T., Michalak, M., Olasińska-Wiśniewska, A., Rodzki, M., Witkowska, A., Gąsecka, A., Buczkowski, P., Perek, B., & Jemielity, M. (2022). Neutrophil Counts, Neutrophil-to-Lymphocyte Ratio, and Systemic Inflammatory Response Index (SIRI) Predict Mortality after Off-Pump Coronary Artery Bypass Surgery. Cells, 11(7), 1124. https://doi.org/10.3390/cells11071124
Han, K., Shi, D., Yang, L., Wang, Z., Li, Y., Gao, F., Liu, Y., Ma, X., & Zhou, Y. (2022). Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Annals of medicine, 54(1), 1667-1677. https://doi.org/10.1080/07853890.2022.2083671
Bao, K., Huang, H., Huang, G., Wang, J., Liao, Y., Pan, Y., Chen, W., Lu, J., Yang, Y., Huang, Z., Chen, S., Chen, K., & Chen, L. (2021). Platelet-to-hemoglobin ratio as a valuable predictor of long-term all-cause mortality in coronary artery disease patients with congestive heart failure. BMC cardiovascular disorders, 21(1), 618. https://doi.org/10.1186/s12872-021-02423-6
Libby P. (2021). Inflammation in Atherosclerosis-No Longer a Theory. Clinical chemistry, 67(1), 131-142. https://doi.org/10.1093/clinchem/hvaa275
Chan, Y. H., & Ramji, D. P. (2020). A perspective on targeting inflammation and cytokine actions in atherosclerosis. Future medicinal chemistry, 12(7), 613-626. https://doi.org/10.4155/fmc-2019-0301
King, A. H., Kwan, S., Schmaier, A. H., Kumins, N. H., Harth, K. C., Colvard, B. D., Wong, V. L., Kashyap, V. S., & Cho, J. S. (2021). Elevated neutrophil to lymphocyte ratio is associated with decreased amputation-free survival after femoropopliteal percutaneous revascularization. International angiology, 40(5), 442-449. https://doi.org/10.23736/S0392-9590.21.04699-X
Zhang, S., Diao, J., Qi, C., Jin, J., Li, L., Gao, X., Gong, L., & Wu, W. (2018). Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis. BMC cardiovascular disorders, 18(1), 75. https://doi.org/10.1186/s12872-018-0812-6
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
